Kaixuan Ma

Kaixuan Ma

Auto-generated profile, based on publicly available information

Kaixuan Ma

Department of Orthopaedics, Changhai Hospital, Navy Medical University 1 , Shanghai

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2024 in Materials Today Bio
Verified
Journal Article
Open access
KMKaixuan Ma
Kaixuan Ma
LYLei Yang
Lei Yang
WLWenzhao Li
Wenzhao Li
KCKai Chen
Kai Chen
LSLuoran Shang
Luoran Shang
YZYuanjin Zhao
Yuanjin Zhao
Hydrogel microspheres hold great promise as scaffolds for bone repair. Their hydrated matrix, biocompatibility, and functional properties make them an attractive choice in regenerative medicine. However, the irregularity of defect requires shape adaptability of the microspheres. Additionally, there is still room for improvement regarding the component of the microspheres to achieve sufficient bioactivity. Here, we prepare multi-bioactive microspheres composed of methacrylated silk fibroin (SFMA) via microfluidic electrospray. Magnesium ascorbyl phosphate (MAP) is encapsulated within the microspheres, whose sustained release facilitates angiogenesis and osteogenic differentiation. The microspheres are further coated with a polydopamine (PDA) layer, allowing them to assemble in situ into a scaffold that conforms to the non-uniform contours of bone defects. The photothermal conversion capability of PDA also provides mild photothermal stimulation to further promote bone regeneration. Based on the synergistic effects, our in vivo experiments demonstrated that the microsphere scaffold effectively promotes bone defect healing. Thus, this multi-bioactive scaffold offers a versatile strategy for bone repair with promising clinical potential.

1 June 2025 in APL Materials
Verified
Journal Article
Open access
ZZZhirui Zhu
Zhirui Zhu
KMKaixuan Ma
Kaixuan Ma
TYTao Yuan
Tao Yuan
BLBo Li
Bo Li
LLLiangle Liu
Liangle Liu
YBYushu Bai
Yushu Bai
Spinal cord injury (SCI) is a severe condition of the central nervous system that leads to significant functional impairments and imposes heavy socioeconomic burdens. Despite recent advancements, traditional treatments remain limited in terms of efficacy and are often associated with complications. Emerging therapies, including stem cell technologies and biomaterials, have shown promise in addressing the challenges associated with SCI recovery. Among these, hydrogels have gained considerable attention, owing to their excellent biocompatibility and adaptability, in addition to their ability to provide an optimal repair microenvironment. Importantly, hydrogels can serve as scaffolds for cell growth, drug delivery systems, or tools for modulating inflammatory responses and oxidative stress. This review comprehensively examines hydrogel-based therapies for the treatment of SCI, focusing on the mechanisms underlying secondary injury. The preparation of hydrogels and their application in promoting nerve regeneration, reducing scar formation, and mitigating oxidative damage are also presented. Furthermore, this review highlights the potential of hydrogels to facilitate macrophage polarization, increase the viability of stem cells, and enhance drug delivery precision. Despite these advancements, challenges remain, including optimization of material properties and achievement of targeted interventions. Future research should focus on developing smart hydrogels that adapt to the SCI microenvironment, investigate the integration of gene and physical therapies, and elucidate the molecular pathways involved in hydrogel-mediated regeneration. With continued innovation, hydrogels hold transformative potential in SCI treatment, being promising for improved functional recovery and patient outcomes.